"The persevering pair who helped open the LSE to cannabis"
09/10/2020
At a glance
In an article published today by BusinessCann, MGC Pharmaceuticals Co-Founder and Managing Director Roby Zomer, and Memery Crystal CEO Nick Davis, speak about their journey over the last year after their application to list MGC Pharma was put on hold. Read the full article below.
“We have been active with the authorities in opening up the market for companies which meet the criteria that we work to. Which is, only legal companies working in the medical cannabis space that meet all of the requirements in the UK not to transgress the Proceeds of Crime Act (PoCA).
“A huge amount of time and money is hopefully going to come to fruition by successfully listing these companies.
“This is all driven by a belief in the industry; a belief in the power of cannabis medicine. This is also about patient access to the medicines that they need and if the capital markets can help secure it, then so much better.” – Memery Crystal CEO Nick Davis
Read the full article here:
The Persevering Pair Who Helped Open The London Stock Exchange To Cannabis
Memery Crystal’s cannabis team
The cannabis sector is a complex area, but Memery Crystal has the expertise to help you navigate it. We are the leading UK law firm advising the emerging cannabis sector on business set-up, capital markets, mergers and acquisitions, private fundraising, regulation, intellectual property & technology and commercial contracts.
Find out more about the work we are doing in the medicinal cannabis sector here.
Contact the author
Nick Davis Senior Partner, Corporate Partner
Contact Nick Davis
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.